Subjective Experience Following Psilocybin

NCT06768944 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Investigating the Importance of the Subjective Psychedelic Experience

Interventions

DRUG: Psilocybin high-dose
DRUG: Psilocybin low-dose
DRUG: Risperidone 1 MG
DRUG: Placebo

Sponsor

University of Calgary